PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
ACRP30 102 Target Disease Diabetes 332,602 27 0.00 -0.86 0.26 0.59
ACRP30 102 Target Disease Cholesterol 182,390 9 0.00 -0.95 0.09 0.58
ACRP30 102 Target Target Collagen 138,882 7 0.00 -0.97 0.07 0.58
ACRP30 102 Target Disease Dyslipidemia 15,225 2 0.00 -0.99 0.02 0.61
ACRP30 102 Target Target EGF 27,487 1 0.00 -1.00 0.01 0.57
ACRP30 102 Target Target Renin 43,456 1 0.00 -1.00 0.01 0.56
ACRP30 102 Target Disease Breast Cancer 173,695 1 0.00 -1.00 0.01 0.53
ACRP30 102 Target Disease Hyperlipidemia 15,317 2 0.00 -0.99 0.02 0.61
ACRP30 102 Target Disease Lung Cancer 91,416 1 0.00 -1.00 0.01 0.55
ACRP30 102 Target Disease Inflammation 252,734 5 0.00 -0.98 0.05 0.56
ACRP30 102 Target Disease Liver Disease 49,817 3 0.00 -0.99 0.03 0.59
ACRP30 102 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.01 0.54
ACRP30 102 Target Target APOE 12,771 3 0.00 -0.99 0.03 0.62
ACRP30 102 Target Disease Chronic Obstructive Pulmonary Disease 27,780 2 0.00 -0.99 0.02 0.59
ACT-2 127 Target Disease Disabilities 28,757 2 0.00 -0.99 0.02 0.59
ACT-2 127 Target Disease Shock 134,031 1 0.00 -1.00 0.01 0.53
ACT-2 127 Target Disease Organ Transplantation 11,384 1 0.00 -1.00 0.01 0.59
ACT-2 127 Target Target Bivalirudin 891 1 0.00 -1.00 0.01 0.67
ACT-2 127 Target Disease HIV/AIDS 20,397 1 0.00 -1.00 0.01 0.58
ACT-2 127 Target Disease Malaria 56,215 2 0.00 -0.99 0.02 0.57
ACT-2 127 Target Disease Cardiac Arrest 20,700 1 0.00 -1.00 0.01 0.58
ACT-2 127 Target Disease Contraception 21,402 1 0.00 -1.00 0.01 0.58
ACT-2 127 Target Disease Histoplasmosis 4,583 1 0.00 -1.00 0.01 0.62
ACT-2 127 Target Disease Inflammation 252,734 2 0.00 -0.99 0.02 0.54
ACT-2 127 Target Target APOE 12,771 1 0.00 -1.00 0.01 0.59
ACT-2 127 Target Target D(2) Dopamine Receptor 1,559 1 0.00 -1.00 0.01 0.65
ACT-2 127 Target Disease Pain 409,851 1 0.00 -1.00 0.01 0.51
ACT-2 127 Target Disease Leukemia 162,805 2 0.00 -0.99 0.02 0.55
ACT-2 127 Target Target BRAF 4,766 1 0.00 -1.00 0.01 0.62
ACT-2 127 Target Disease Asthma 109,610 1 0.00 -1.00 0.01 0.54
ACTG1 41 Target Disease Shock 134,031 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Disease Retinitis 9,116 1 0.00 -0.99 0.02 0.62
ACTG1 41 Target Disease Acute Promyelocytic Leukemia 4,780 1 0.00 -0.99 0.02 0.63
ACTG1 41 Target Disease Tuberculosis 146,217 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Disease Infection 766,637 2 0.00 -0.98 0.05 0.53
ACTG1 41 Target Disease Hepatitis B 57,815 1 0.00 -0.99 0.02 0.57
ACTG1 41 Target Target B2M 677 1 0.01 -0.99 0.02 0.69
ACTG1 41 Target Disease Muscle Weakness 9,178 2 0.00 -0.98 0.05 0.64
ACTG1 41 Target Target CALR 117 1 0.01 -0.98 0.02 0.76
ACTG1 41 Target Disease Breast Cancer 173,695 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Disease Leukemia 162,805 2 0.00 -0.98 0.05 0.57
ACTG1 41 Target Disease Amyotrophic Lateral Sclerosis 14,006 1 0.00 -0.99 0.02 0.61
ACTG1 41 Target Disease Disabilities 28,757 1 0.00 -0.99 0.02 0.59
ACTG1 41 Target Target AHSG 176 1 0.01 -0.98 0.02 0.74
ACTG1 41 Target Disease Hepatitis 163,842 1 0.00 -0.99 0.02 0.55
ACTG1 41 Target Disease Inflammation 252,734 1 0.00 -0.99 0.02 0.54
ACVR1B 23 Target Target Activin A 2,048 5 0.02 -0.88 0.22 0.72
ACVR1B 23 Target Disease Inflammation 252,734 1 0.00 -0.98 0.04 0.55
ACVR1B 23 Target Disease Lung Cancer 91,416 2 0.00 -0.96 0.09 0.59
ACVR1B 23 Target Target ERBB3 1,154 1 0.01 -0.98 0.04 0.68